Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMD14 | O00487 | 2/20 | 0.50 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.50 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.31 |
| ▸ | APAF1 | O14727 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GRK2 | P25098 | 1/20 | 0.30 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.30 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.30 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.30 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL9242383 | 0.98 | PSMD14 (0.49) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL8712214 | 0.85 | PSMD14 (0.50) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL17991834 | 0.81 | PSMD14 (0.47) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Water SCHEMBL9246364 | 0.81 | PSMD14 (0.32) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL2841240 | 0.80 | APP (0.36) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL12715831 | 0.80 | PSMD14 (0.33) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL13133627 | 0.79 | MAPT (0.43) | BLMLMNA | |
| SCHEMBL6237613 | 0.79 | PLA2G1B (0.53) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL10937702 | 0.79 | PLA2G1B (0.53) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL11770996 | 0.79 | PLA2G1B (0.53) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8962338-B2 | Methods for measurement of calcium ions | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2015-02-24 | — | — | US | claimed |
| EP-2553469-B1 | METHOD FOR MEASUREMENT OF CALCIUM IONS | ROCHE DIAGNOSTICS GMBH (DE) | 2015-01-14 | — | — | EP | claimed |
| EP-2553469-A1 | METHOD FOR MEASUREMENT OF CALCIUM IONS | Roche Diagniostics GmbH (DE) | 2013-02-06 | — | — | EP | claimed |
| US-20130023055-A1 | METHODS FOR MEASUREMENT OF CALCIUM IONS | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2013-01-24 | — | — | US | claimed |
| WO-2011120913-A1 | METHOD FOR MEASUREMENT OF CALCIUM IONS | ROCHE DIAGNOSTICS GMBH (DE) | 2011-10-06 | — | — | WO | claimed |
| US-8962338-B2 | Methods for measurement of calcium ions | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2015-02-24 | — | — | US | disclosed |
| EP-2553469-B1 | METHOD FOR MEASUREMENT OF CALCIUM IONS | ROCHE DIAGNOSTICS GMBH (DE) | 2015-01-14 | — | — | EP | disclosed |
| EP-2553469-A1 | METHOD FOR MEASUREMENT OF CALCIUM IONS | Roche Diagniostics GmbH (DE) | 2013-02-06 | — | — | EP | disclosed |
| US-20130023055-A1 | METHODS FOR MEASUREMENT OF CALCIUM IONS | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2013-01-24 | — | — | US | disclosed |
| WO-2011120913-A1 | METHOD FOR MEASUREMENT OF CALCIUM IONS | ROCHE DIAGNOSTICS GMBH (DE) | 2011-10-06 | — | — | WO | disclosed |
| US-7732146-B2 | Method for screening an agent that modulates activity of macrophage migration inhibitory factor | AVANIR PHARMACEUTICALS (US) | 2010-06-08 | — | — | US | disclosed |
| EP-1389110-B1 | INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND METHODS FOR IDENTIFYING THE SAME | AVANIR PHARMACEUTICALS (US) | 2010-03-24 | — | — | EP | disclosed |
| EP-0999850-A2 | METHODS AND COMPOSITIONS FOR REGULATING NUCLEAR TRAFFICKING OF PROTEINS | Ciblex Corporation (US) | 2000-05-17 | — | — | EP | disclosed |
| US-6028058-A | INHIBITING NUCLEAR LOCALIZATION OF HIGH MOLECULAR WEIGHT FORMS OF FGF-2, COMPRISING ADMINISTERING TO CELL EFFECTIVE AMOUNT OF POLYPEPTIDE | CIBLEX CORPORATION (US) | 2000-02-22 | — | — | US | disclosed |
| EP-0941733-A2 | Methods of inhibiting leaderless protein export using cardiac glycosides and derivatives | The Scripps Research Institute (US) | 1999-09-15 | — | — | EP | disclosed |
| EP-0828497-B1 | METHODS OF INHIBITING LEADERLESS PROTEIN EXPORT USING CARDIAC GLYCOSIDES OR AGLYCONES THEREFROM AND DERIVATIVES | SCRIPPS RESEARCH INST (US) | 1999-09-01 | — | — | EP | disclosed |
| WO-1999003489-A2 | METHODS AND COMPOSITIONS FOR REGULATING NUCLEAR TRAFFICKING OF PROTEINS | CIBLEX CORPORATION (US) | 1999-01-28 | — | — | WO | disclosed |
| WO-1998037880-A1 | INHIBITORS OF LEADERLESS PROTEIN EXPORT | CIBLEX CORPORATION (US) | 1998-09-03 | — | — | WO | disclosed |
| EP-0828497-A1 | METHODS OF INHIBITING LEADERLESS PROTEIN EXPORT USING CARDIAC GLYCOSIDES OR AGLYCONES THEREFROM AND DERIVATIVES | The Scripps Research Institute (US) | 1998-03-18 | — | — | EP | disclosed |
| WO-1997028808-A1 | METHODS OF INHIBITING LEADERLESS PROTEIN EXPORT USING CARDIAC GLYCOSIDES OR AGLYCONES THEREFROM AND DERIVATIVES | THE SCRIPPS RESEARCH INSTITUTE (US) | 1997-08-14 | — | — | WO | disclosed |